Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease



Status:Archived
Conditions:Alzheimer Disease, Cognitive Studies
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:December 2009
End Date:December 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Principal Open-label Study to Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease


This study will investigate the efficacy of the Flutemetamol (18F) Injection PET tracer in
identifying abnormal (18F) flutemetamol uptake patterns which predict the conversion from
aMCI to a b-amyloid associated clinically probable Alzheimer's disease.



We found this trial at
1
site
GE Healthcare
Princeton, New Jersey 08540
?
mi
from
Princeton, NJ
Click here to add this to my saved trials